1. Home
  2. CSBR vs NNOX Comparison

CSBR vs NNOX Comparison

Compare CSBR & NNOX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Champions Oncology Inc.

CSBR

Champions Oncology Inc.

N/A

Current Price

$4.90

Market Cap

68.8M

Sector

Health Care

ML Signal

N/A

Logo NANO-X IMAGING LTD

NNOX

NANO-X IMAGING LTD

HOLD

Current Price

$0.51

Market Cap

69.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CSBR
NNOX
Founded
1985
2011
Country
United States
Israel
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Medical Electronics
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
68.8M
69.6M
IPO Year
2015
2019

Fundamental Metrics

Financial Performance
Metric
CSBR
NNOX
Price
$4.90
$0.51
Analyst Decision
Buy
Analyst Count
0
3
Target Price
N/A
★ $4.13
AVG Volume (30 Days)
12.8K
★ 770.9K
Earning Date
09-10-2026
11-19-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ N/A
EPS
N/A
★ N/A
Revenue
★ $2,900,000.00
N/A
Revenue This Year
$9.83
$71.03
Revenue Next Year
$8.50
$86.15
P/E Ratio
★ N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$4.59
$0.50
52 Week High
$8.31
$4.71

Technical Indicators

Market Signals
Indicator
CSBR
NNOX
Relative Strength Index (RSI) 47.28 28.97
Support Level $4.81 N/A
Resistance Level $6.29 $1.16
Average True Range (ATR) 0.16 0.04
MACD 0.00 -0.01
Stochastic Oscillator 45.65 6.39

Price Performance

Historical Comparison
CSBR
NNOX

About CSBR Champions Oncology Inc.

Champions Oncology Inc is a USA based company which is engaged in the development and sale of state of the art technology solutions and products to personalize the development and use of oncology drugs. The company operates through one segment which is oncology services. Its research center operates in both regulatory and non-regulatory environments and consists of a comprehensive set of computational and experimental research platforms. The company's pharmacology, biomarker, and data platforms are designed to facilitate drug discovery and development at lower costs and increased speeds. Its revenue is majorly derived from research services.

About NNOX NANO-X IMAGING LTD

Nano X Imaging Ltd is focused on driving the world's transition to preventive health care by delivering an integrated, end-to-end medical imaging and healthcare services platform. The group combines affordable imaging hardware, progressive AI-based solutions, cloud-based software, access to remote radiology, health IT solutions, and a marketplace to enable earlier detection, improved clinical efficiency, and broader access to care. The three segments are composed of the Nanox.ARC segment, the AI and software solutions segment, and the Radiology services segment. Key revenue is generated from Radiology Services.

Share on Social Networks: